Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Chronic rhinitis, Rhinorrhea, Hearing loss (hearing impairment), and Situs inversus totalis and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lungs and breathing | 2 | Bronchiectasis, Wheezing |
Hormones |
DNAH1 encodes dynein axonemal heavy chain 1 (4,265 aa). Force generating protein of cilia required for sperm flagellum motility. Produces force towards the minus ends of microtubules. Highest expression in Testis (27.4 TPM) and Spleen (12.4 TPM).
Ciliary dyskinesia, primary, 37 is associated with mutations in the DNAH1 gene on chromosome 3.
DNAH1 is classified as a druggable target with score 0.0.
Genetic testing for DNAH1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 11 always present features.
No clinical trials have been registered for ciliary dyskinesia, primary, 37.
112 publications have been identified in PubMed for ciliary dyskinesia, primary, 37. Kisho has analyzed 23 by research type. Research spans Review / Meta-Analysis (48%), Epidemiology / Natural History (26%), and Basic Science / Preclinical (13%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 11 | 48% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 12:41 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about ciliary dyskinesia, primary, 37
2 |
Female infertility, Hypothyroidism |
Ears | 1 | Hearing loss (hearing impairment) |
Heart and blood vessels | 1 | Right aortic arch |
Disease patterns and progression |
6 |
26% |
Laboratory research | 3 | 13% |
Patient case studies | 2 | 9% |
New treatment approaches | 1 | 4% |
Benjamin AT (2026). [PMID: 41721661](https://pubmed.ncbi.nlm.nih.gov/41721661/). *Lung India*. [Epidemiology / Natural History]
Jiang T (2026). [PMID: 41945498](https://pubmed.ncbi.nlm.nih.gov/41945498/). *J Minim Access Surg*. [Case Report / Case Series]
Haarman EG (2026). [PMID: 41928691](https://pubmed.ncbi.nlm.nih.gov/41928691/). *Pediatr Pulmonol*. [Review / Meta-Analysis]
Smith H (2026). [PMID: 41689271](https://pubmed.ncbi.nlm.nih.gov/41689271/). *Pediatr Pulmonol*. [Review / Meta-Analysis]
Ito M (2026). [PMID: 41570615](https://pubmed.ncbi.nlm.nih.gov/41570615/). *Respir Investig*. [Epidemiology / Natural History]
Harman K (2026). [PMID: 41889169](https://pubmed.ncbi.nlm.nih.gov/41889169/). *Pediatr Pulmonol*. [Review / Meta-Analysis]
Rizk H (2025). [PMID: 41078601](https://pubmed.ncbi.nlm.nih.gov/41078601/). *Front Mol Biosci*. [Epidemiology / Natural History]
Ferkol T (2025). [PMID: 39466027](https://pubmed.ncbi.nlm.nih.gov/39466027/). *Pediatr Pulmonol*. [Review / Meta-Analysis]
Krämer C (2025). [PMID: 40169130](https://pubmed.ncbi.nlm.nih.gov/40169130/). *Pneumologie*. [Review / Meta-Analysis]
Shoemark A (2025). [PMID: 41005984](https://pubmed.ncbi.nlm.nih.gov/41005984/). *Eur Respir J*. [Review / Meta-Analysis]